Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gottfried von Keudell

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Hematology|June 9, 2021
The role of tazemetostat in relapsed/refractory follicular lymphomaGottfried von Keudell, Gilles Salles
British Journal of Haematology|December 12, 2018
Novel therapeutic agents for relapsed classical Hodgkin lymphomaGottfried von Keudell, Anas Younes
Best Practice & Research. Clinical Haematology|March 12, 2025
Bispecific antibody therapy for lymphomaGenevieve M Gerhard, Gottfried von Keudell
Current Hematologic Malignancy Reports|July 31, 2019
The Role of PI3K Inhibition in Lymphoid MalignanciesGottfried von Keudell, Alison J Moskowitz
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 30, 2014
Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosisGottfried von Keudell, Vaishali Sanchorawala, Carl O'Hara, et al.
Journal of Hematology & Oncology|January 7, 2021
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)Melissa Lumish, Lorenzo Falchi, Brandon S Imber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2018
Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin LymphomaScott F Huntington, Gottfried von Keudell, Amy J Davidoff, et al.
Nature Reviews. Disease Primers|December 14, 2019
Follicular lymphomaAntonino Carbone, Sandrine Roulland, Annunziata Gloghini, et al.
Blood Advances|July 17, 2025
Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysisAlberto Guijosa, Andres Ramirez-Gamero, Shayna Sarosiek, et al.
Oncotarget|October 14, 2015
PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENPXiaolan Deng, Gottfried Von Keudell, Takehiro Suzuki, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Hematology|June 9, 2021
The role of tazemetostat in relapsed/refractory follicular lymphomaGottfried von Keudell, Gilles Salles
British Journal of Haematology|December 12, 2018
Novel therapeutic agents for relapsed classical Hodgkin lymphomaGottfried von Keudell, Anas Younes
Best Practice & Research. Clinical Haematology|March 12, 2025
Bispecific antibody therapy for lymphomaGenevieve M Gerhard, Gottfried von Keudell
Current Hematologic Malignancy Reports|July 31, 2019
The Role of PI3K Inhibition in Lymphoid MalignanciesGottfried von Keudell, Alison J Moskowitz
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 30, 2014
Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosisGottfried von Keudell, Vaishali Sanchorawala, Carl O'Hara, et al.
Journal of Hematology & Oncology|January 7, 2021
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)Melissa Lumish, Lorenzo Falchi, Brandon S Imber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2018
Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin LymphomaScott F Huntington, Gottfried von Keudell, Amy J Davidoff, et al.
Nature Reviews. Disease Primers|December 14, 2019
Follicular lymphomaAntonino Carbone, Sandrine Roulland, Annunziata Gloghini, et al.
Blood Advances|July 17, 2025
Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysisAlberto Guijosa, Andres Ramirez-Gamero, Shayna Sarosiek, et al.
Oncotarget|October 14, 2015
PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENPXiaolan Deng, Gottfried Von Keudell, Takehiro Suzuki, et al.
Pageof 3